MeSH term
Frequency | Condition_Probility | Female | 35 | 0.0 |
Humans | 218 | 0.0 |
Acute Disease | 3 | 0.0 |
Adult | 31 | 0.0 |
Bone Marrow Transplantation/*statistics & numerical data | 2 | 2.0 |
Comparative Study | 27 | 0.0 |
Cord Blood Stem Cell Transplantation/*statistics & numerical data | 2 | 2.0 |
Fetal Blood/transplantation | 2 | 2.0 |
Leukemia/*therapy | 2 | 1.0 |
Patient Selection | 2 | 1.0 |
Aged | 15 | 0.0 |
Aged, 80 and over | 9 | 0.0 |
Fatal Outcome | 2 | 0.0 |
Animals | 65 | 0.0 |
Gene Expression | 7 | 0.0 |
*Chemotaxis, Leukocyte | 2 | 2.0 |
Cytokines/biosynthesis | 14 | 2.0 |
Research Support, Non-U.S. Gov't | 149 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 59 | 0.0 |
Chemokines/*physiology | 2 | 6.0 |
Antigens, CD27/analysis | 2 | 11.0 |
Antigens, CD28/analysis | 3 | 8.0 |
Antigens, CD45/analysis | 3 | 1.0 |
Cytotoxicity, Immunologic | 4 | 0.0 |
Herpesvirus 4, Human/immunology | 3 | 4.0 |
*Immunologic Memory | 9 | 6.0 |
Immunophenotyping | 27 | 0.0 |
Receptors, CCR5/analysis | 3 | 6.0 |
Receptors, Chemokine/analysis | 9 | 30.0 |
T-Lymphocyte Subsets/*immunology | 4 | 0.0 |
CD8-Positive T-Lymphocytes/chemistry/*immunology | 2 | 33.0 |
Cell Differentiation | 15 | 0.0 |
Cytomegalovirus/*immunology | 4 | 6.0 |
Receptors, Chemokine/*analysis | 6 | 16.0 |
Viral Matrix Proteins/immunology | 2 | 20.0 |
Cell Movement | 14 | 1.0 |
Chemokines, CC/physiology | 5 | 38.0 |
Chemotaxis | 13 | 7.0 |
Cytokines/*biosynthesis | 3 | 0.0 |
Mice | 42 | 0.0 |
Mice, Inbred BALB C | 8 | 0.0 |
Receptors, Chemokine/analysis/*physiology | 2 | 40.0 |
Actins/metabolism | 3 | 0.0 |
Calcium/metabolism | 8 | 0.0 |
Chemokines, CC/pharmacology | 4 | 12.0 |
Lymph Nodes/*pathology | 2 | 2.0 |
Lymphatic Metastasis | 6 | 0.0 |
Male | 32 | 0.0 |
Neoplasm Invasiveness | 4 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Receptors, Chemokine/*biosynthesis/genetics | 5 | 17.0 |
Tumor Cells, Cultured | 9 | 0.0 |
*Antiretroviral Therapy, Highly Active | 3 | 0.0 |
CD4-Positive T-Lymphocytes/*immunology | 5 | 0.0 |
Lymphocyte Count | 4 | 0.0 |
Time Factors | 12 | 0.0 |
Antigens, CD1/biosynthesis | 2 | 12.0 |
Antigens, CD40/biosynthesis | 3 | 11.0 |
Biological Markers/analysis | 4 | 0.0 |
Cell Communication/immunology | 2 | 2.0 |
Cell Differentiation/immunology | 16 | 4.0 |
Cell Movement/*immunology | 7 | 10.0 |
Chemokines/*biosynthesis | 2 | 6.0 |
HLA-DR Antigens/biosynthesis | 5 | 5.0 |
Immunoglobulins/biosynthesis | 4 | 3.0 |
Membrane Glycoproteins/biosynthesis | 8 | 5.0 |
Receptors, Chemokine/biosynthesis | 13 | 26.0 |
Cells, Cultured | 41 | 0.0 |
Lymphocyte Activation | 20 | 0.0 |
T-Lymphocyte Subsets/immunology/*metabolism | 3 | 8.0 |
Chemotaxis, Leukocyte/*immunology | 3 | 6.0 |
Immunologic Memory | 25 | 8.0 |
In Vitro | 10 | 0.0 |
Receptors, Chemokine/*metabolism | 18 | 12.0 |
Receptors, Cytokine/metabolism | 2 | 2.0 |
Antigens, CD/analysis | 7 | 0.0 |
Cell Culture Techniques | 4 | 0.0 |
Cell Movement/immunology | 6 | 6.0 |
Flow Cytometry | 29 | 0.0 |
Cell Polarity | 3 | 2.0 |
Interferon Type II/biosynthesis | 9 | 1.0 |
Interleukin-4/biosynthesis | 2 | 1.0 |
Receptors, Cytokine/*analysis | 2 | 12.0 |
Arthritis, Rheumatoid/*immunology | 2 | 0.0 |
Cell Line | 18 | 0.0 |
Chemokines/metabolism | 8 | 11.0 |
RANTES/metabolism | 2 | 3.0 |
Receptors, CCR5/metabolism | 4 | 2.0 |
Receptors, Chemokine/metabolism | 18 | 15.0 |
T-Lymphocytes/*immunology | 5 | 0.0 |
Adolescent | 7 | 0.0 |
Antigens, CD45/biosynthesis | 3 | 5.0 |
Cell Line, Transformed | 2 | 0.0 |
HLA-A2 Antigen/metabolism | 2 | 12.0 |
Herpesvirus 4, Human/*immunology | 4 | 5.0 |
*Immunophenotyping | 5 | 2.0 |
Protein Binding/immunology | 2 | 1.0 |
Receptors, Lymphocyte Homing/biosynthesis | 2 | 11.0 |
*Chemotaxis | 3 | 9.0 |
Integrin alpha4 | 2 | 5.0 |
Ligands | 26 | 0.0 |
Middle Aged | 22 | 0.0 |
Receptors, Chemokine/metabolism/*physiology | 2 | 22.0 |
Chemotaxis/immunology | 2 | 14.0 |
*Homeostasis | 2 | 3.0 |
Macaca mulatta | 4 | 0.0 |
Simian Acquired Immunodeficiency Syndrome/*pathology | 2 | 100.0 |
Antibody Specificity | 4 | 0.0 |
CD8-Positive T-Lymphocytes/*immunology | 6 | 1.0 |
Clone Cells | 4 | 0.0 |
Culture Media, Conditioned | 3 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Infant | 4 | 0.0 |
Interleukin-2/pharmacology | 3 | 0.0 |
Acquired Immunodeficiency Syndrome/*immunology | 2 | 0.0 |
Antigens, CD/immunology | 10 | 2.0 |
Dendritic Cells/immunology | 3 | 2.0 |
HIV Infections/*immunology | 3 | 0.0 |
HIV-1/*immunology | 5 | 1.0 |
Receptors, Chemokine/immunology | 11 | 34.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Gene Expression/immunology | 2 | 2.0 |
Receptors, Interleukin-2/metabolism | 2 | 1.0 |
Antigens/immunology | 2 | 1.0 |
Cell Movement/physiology | 6 | 2.0 |
Chemokines, CC/*physiology | 3 | 21.0 |
Cloning, Molecular | 5 | 0.0 |
Lymphoid Tissue/cytology | 2 | 9.0 |
Mice, Inbred C57BL | 8 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Receptors, Chemokine/*physiology | 4 | 9.0 |
Chemokines/*metabolism | 3 | 5.0 |
Mice, Knockout | 4 | 0.0 |
Receptors, Chemokine/genetics/*physiology | 2 | 18.0 |
Cell Lineage | 2 | 0.0 |
Chemotaxis, Leukocyte | 9 | 4.0 |
Cytotoxicity Tests, Immunologic | 5 | 1.0 |
HIV Antigens/*immunology | 2 | 3.0 |
HIV-1/immunology | 4 | 5.0 |
T-Lymphocyte Subsets/classification/immunology | 2 | 40.0 |
RNA, Messenger/metabolism | 8 | 0.0 |
Receptors, Chemokine/genetics/metabolism/*physiology | 2 | 33.0 |
Up-Regulation | 7 | 0.0 |
*Cytotoxicity, Immunologic | 4 | 0.0 |
Killer Cells, Natural/*immunology | 3 | 0.0 |
ADP-ribosyl Cyclase/analysis | 2 | 9.0 |
L-Selectin/analysis | 2 | 10.0 |
Cell Differentiation/drug effects/*immunology | 2 | 25.0 |
T-Lymphocyte Subsets/cytology/*immunology | 2 | 8.0 |
Dendritic Cells/*physiology | 8 | 10.0 |
*Drosophila Proteins | 3 | 0.0 |
Receptors, Chemokine/physiology | 3 | 11.0 |
Chemokines/*pharmacology | 2 | 7.0 |
T-Lymphocytes/metabolism | 4 | 1.0 |
*Lymphatic Metastasis | 2 | 5.0 |
Antigen Presentation | 5 | 1.0 |
Gene Expression Regulation/drug effects | 3 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology | 3 | 0.0 |
Immunization | 3 | 0.0 |
Interferon Type II/biosynthesis/genetics | 2 | 5.0 |
Interferon-alpha/pharmacology | 2 | 2.0 |
Interleukin-4/pharmacology | 5 | 1.0 |
Mice, SCID | 7 | 0.0 |
Transplantation, Heterologous | 3 | 0.0 |
Adjuvants, Immunologic/*pharmacology | 5 | 3.0 |
CD4-Positive T-Lymphocytes/immunology | 6 | 0.0 |
Cell Movement/drug effects | 5 | 1.0 |
Membrane Glycoproteins/*biosynthesis | 2 | 2.0 |
Receptors, Cell Surface/*biosynthesis | 2 | 3.0 |
Th1 Cells/immunology | 2 | 1.0 |
Cell Line, Tumor | 9 | 0.0 |
English Abstract | 2 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Chemokines, CC/metabolism | 3 | 6.0 |
Chemokines, CXC/metabolism | 4 | 5.0 |
Chemotaxis/physiology | 3 | 9.0 |
Disease Models, Animal | 2 | 0.0 |
Macrophage Inflammatory Protein-1/metabolism | 2 | 3.0 |
Molecular Sequence Data | 11 | 0.0 |
Models, Biological | 4 | 0.0 |
Cytokines/secretion | 4 | 5.0 |
Chemotaxis, Leukocyte/immunology | 4 | 6.0 |
Dendritic Cells/cytology/*immunology/*metabolism | 3 | 27.0 |
Case-Control Studies | 6 | 0.0 |
Cell Differentiation/*immunology | 2 | 7.0 |
Cell Adhesion | 5 | 0.0 |
Lipopolysaccharides/pharmacology | 6 | 0.0 |
*Receptors, Chemokine | 3 | 3.0 |
CD8-Positive T-Lymphocytes/*immunology/virology | 2 | 11.0 |
L-Selectin/metabolism | 4 | 12.0 |
B-Lymphocytes/*immunology | 5 | 0.0 |
Chemokines, CXC/pharmacology | 6 | 8.0 |
Child | 8 | 0.0 |
Child, Preschool | 4 | 0.0 |
Biological Markers | 3 | 0.0 |
*Immunotherapy | 2 | 1.0 |
Phenotype | 15 | 0.0 |
Cell Movement/*physiology | 5 | 2.0 |
Antigens, CD/*biosynthesis | 2 | 1.0 |
Coculture Techniques | 10 | 1.0 |
Dose-Response Relationship, Immunologic | 2 | 0.0 |
Up-Regulation/immunology | 4 | 2.0 |
Immunohistochemistry/methods | 3 | 0.0 |
Receptors, Chemokine/genetics/*metabolism | 2 | 4.0 |
Chemokines, CC/metabolism/pharmacology | 2 | 12.0 |
Down-Regulation | 6 | 0.0 |
Fetal Blood | 2 | 1.0 |
Interleukin-1/metabolism | 2 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Receptors, Chemokine/*genetics | 7 | 7.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cell Culture Techniques/*methods | 2 | 2.0 |
Cell Proliferation/drug effects | 2 | 2.0 |
Cytokines/*pharmacology | 2 | 0.0 |
Dendritic Cells/*cytology/drug effects/immunology | 2 | 20.0 |
Lymphocyte Culture Test, Mixed | 6 | 0.0 |
Membrane Glycoproteins/immunology/metabolism | 2 | 6.0 |
Microscopy, Confocal | 3 | 0.0 |
Immunoglobulins/analysis | 2 | 0.0 |
Membrane Glycoproteins/analysis | 2 | 0.0 |
Dendritic Cells/drug effects/immunology | 2 | 50.0 |
Cell Division | 3 | 0.0 |
Cytomegalovirus/immunology | 6 | 8.0 |
Epitopes, T-Lymphocyte/immunology | 3 | 3.0 |
Leukopoiesis | 2 | 16.0 |
T-Lymphocyte Subsets/immunology | 6 | 1.0 |
Lung/pathology | 2 | 2.0 |
Neoplasm Transplantation | 2 | 0.0 |
Injections, Intradermal | 2 | 4.0 |
Cytokines/pharmacology | 3 | 0.0 |
*Receptors, G-Protein-Coupled | 3 | 1.0 |
Receptors, Lymphocyte Homing/metabolism | 3 | 8.0 |
*Receptors, Virus | 2 | 8.0 |
*Cell Movement | 2 | 1.0 |
Lymph Nodes/*metabolism/pathology | 2 | 20.0 |
Lymphocyte Activation/immunology | 7 | 1.0 |
Receptors, CXCR4/*metabolism | 2 | 1.0 |
Chemokines/*immunology | 2 | 10.0 |
Dendritic Cells/*immunology/metabolism | 4 | 8.0 |
Inflammation/immunology | 2 | 1.0 |
Skin/cytology/immunology/metabolism | 2 | 50.0 |
*Antibody Formation | 2 | 2.0 |
Cell Fractionation | 2 | 0.0 |
Germinal Center/cytology/immunology | 2 | 28.0 |
Immunologic Memory/immunology | 3 | 7.0 |
Leukocytes, Mononuclear/metabolism | 2 | 0.0 |
*Membrane Transport Proteins | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 4 | 0.0 |
Receptors, Chemokine/biosynthesis/genetics | 3 | 16.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Apoptosis/*immunology | 2 | 1.0 |
Cell Division/immunology | 9 | 3.0 |
Down-Regulation/immunology | 2 | 2.0 |
Protein Biosynthesis | 3 | 0.0 |
Signal Transduction/*immunology | 2 | 0.0 |
Hematopoietic Stem Cells/*physiology | 2 | 1.0 |
Lymphoid Tissue/cytology/immunology | 2 | 20.0 |
Base Sequence | 4 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
In Situ Hybridization | 4 | 0.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Antigens, CD45/metabolism | 2 | 2.0 |
*Integrin beta Chains | 2 | 12.0 |
Integrins/metabolism | 2 | 1.0 |
T-Lymphocytes/immunology | 3 | 0.0 |
Dendritic Cells/metabolism | 4 | 9.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Leukocytes/metabolism | 3 | 2.0 |
Mutation | 5 | 0.0 |
Peptides/chemistry | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Spleen/cytology | 2 | 1.0 |
T-Lymphocytes/*metabolism | 3 | 0.0 |
Transfection | 11 | 0.0 |
Antigens, CD40/metabolism | 2 | 3.0 |
CD40 Ligand | 2 | 1.0 |
Membrane Glycoproteins/pharmacology | 2 | 3.0 |
Cell Division/drug effects | 3 | 0.0 |
Chemokines, CC/*pharmacology | 3 | 14.0 |
*Macrophage Inflammatory Proteins | 2 | 12.0 |
Dendritic Cells/*cytology | 2 | 3.0 |
Mice, Mutant Strains | 2 | 0.0 |
Gene Expression Profiling | 5 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Immunoblotting | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 10 | 0.0 |
Macrophage Inflammatory Protein-1/pharmacology | 3 | 6.0 |
RANTES/pharmacology | 3 | 5.0 |
Receptors, Chemokine/*immunology | 2 | 7.0 |
*Apoptosis | 2 | 0.0 |
Interleukin-12/biosynthesis | 2 | 2.0 |
Monocytes/*cytology | 3 | 3.0 |
Protein Subunits/biosynthesis | 2 | 15.0 |
Tumor Necrosis Factor-alpha/biosynthesis | 3 | 0.0 |
Chemotaxis/*drug effects | 3 | 6.0 |
Recombinant Proteins/pharmacology | 3 | 0.0 |
Fetal Blood/cytology/immunology | 2 | 5.0 |
Infant, Newborn | 3 | 0.0 |
Receptors, CCR5/genetics | 2 | 3.0 |
T-Lymphocytes/*immunology/metabolism | 2 | 1.0 |
Dendritic Cells/*metabolism | 3 | 4.0 |
Kinetics | 5 | 0.0 |
Chemokines, CC/*metabolism | 4 | 7.0 |
Lymphocyte Subsets/physiology | 2 | 22.0 |
Chemokines, CC/metabolism/*physiology | 4 | 66.0 |
Species Specificity | 2 | 0.0 |
Chemotaxis, Leukocyte/*drug effects | 2 | 3.0 |
Polymerase Chain Reaction | 2 | 0.0 |
CD8-Positive T-Lymphocytes/immunology | 4 | 0.0 |
Cytokines/metabolism | 2 | 0.0 |
Hepacivirus/*immunology | 2 | 6.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
Dendritic Cells/cytology/*immunology | 2 | 3.0 |
Antigens, CD/genetics | 2 | 1.0 |
Receptors, CXCR4/metabolism | 5 | 3.0 |
Cell Differentiation/drug effects/immunology | 2 | 2.0 |
Cell Movement/drug effects/*immunology | 3 | 21.0 |
Chemokines, CC/immunology/pharmacology | 2 | 100.0 |
Th2 Cells/*immunology | 2 | 1.0 |
Lymph Nodes/cytology | 2 | 4.0 |
Receptors, Cell Surface/genetics | 2 | 1.0 |
Chemokines, CC/*biosynthesis | 2 | 10.0 |
Lymph Nodes/cytology/immunology | 3 | 12.0 |
Lymphoid Tissue/*immunology | 2 | 7.0 |
*Cell Adhesion | 2 | 1.0 |
Lymphocytes/*physiology | 2 | 2.0 |
Statistics, Nonparametric | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Gene Library | 2 | 0.0 |
Receptors, Cell Surface/*metabolism | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Chronic Disease | 6 | 0.0 |
Vaccination | 2 | 1.0 |
Virus Replication | 2 | 0.0 |
Lymphocyte Activation/*immunology | 7 | 1.0 |
DNA Primers/chemistry | 2 | 0.0 |
Immunohistochemistry | 8 | 0.0 |
Lymph Nodes/pathology | 4 | 1.0 |
RNA/metabolism | 2 | 0.0 |
Chemokines, CC/*metabolism/physiology | 2 | 50.0 |
Hamsters | 2 | 0.0 |
Inflammation/immunology/metabolism | 2 | 11.0 |
Immunity, Cellular | 2 | 0.0 |
Signal Transduction/genetics/*immunology | 2 | 2.0 |
Solubility | 2 | 0.0 |
Cell Differentiation/drug effects | 5 | 0.0 |
Disease Progression | 2 | 0.0 |
Neoplasm Staging | 3 | 0.0 |
Prognosis | 2 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 4 | 0.0 |
Phosphorylation | 3 | 0.0 |
Leukocytes, Mononuclear/drug effects/metabolism | 2 | 3.0 |
Antigens, CD28/immunology | 2 | 1.0 |
Rabbits | 2 | 0.0 |
Receptors, Chemokine/blood/*metabolism | 2 | 66.0 |
T-Lymphocytes/drug effects/*immunology | 2 | 1.0 |
Viral Load | 2 | 0.0 |
Dendritic Cells/*immunology | 3 | 1.0 |
Th1 Cells/*immunology | 2 | 1.0 |
Antigen-Presenting Cells/*immunology | 2 | 1.0 |
Neoplasm Metastasis | 2 | 0.0 |
NF-kappa B/metabolism | 4 | 0.0 |
Antigens, CD3/immunology | 2 | 0.0 |
Fetal Blood/cytology/immunology/metabolism | 2 | 33.0 |
Interphase/*immunology | 2 | 22.0 |
Receptors, Antigen, T-Cell, alpha-beta/biosynthesis | 2 | 9.0 |
Signal Transduction/immunology | 2 | 0.0 |
Antigens, Surface/immunology | 2 | 1.0 |
Membrane Glycoproteins/immunology | 2 | 1.0 |
Antigens, CD/biosynthesis | 4 | 1.0 |
CD8-Positive T-Lymphocytes/cytology/*immunology/metabolism/*virology | 2 | 66.0 |
Dendritic Cells/cytology/*drug effects/immunology | 2 | 16.0 |
HLA-DR Antigens/analysis | 2 | 0.0 |
*Lymphocyte Activation | 2 | 0.0 |
T-Lymphocytes/cytology/immunology | 2 | 2.0 |
Interleukin-2/immunology | 2 | 1.0 |
Interleukin-4/immunology | 2 | 3.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Receptors, Chemokine/*genetics/metabolism | 2 | 14.0 |
Signal Transduction | 2 | 0.0 |
Cell Separation | 2 | 0.0 |
Interleukin-12/metabolism | 3 | 5.0 |
Immunologic Memory/*immunology | 2 | 6.0 |
Lymph Nodes/immunology | 3 | 3.0 |
Antigens, CD8/biosynthesis | 2 | 5.0 |
Receptors, Chemokine/*biosynthesis | 3 | 7.0 |
Monocytes/cytology/*immunology/metabolism | 2 | 16.0 |
Receptors, Chemokine/immunology/metabolism | 2 | 33.0 |
Receptors, Antigen, T-Cell, gamma-delta/*immunology | 2 | 4.0 |
Adoptive Transfer | 2 | 2.0 |
Microspheres | 2 | 1.0 |
Skin/immunology | 2 | 2.0 |
Antigens, CD | 2 | 1.0 |
Chemotaxis, Leukocyte/drug effects | 2 | 2.0 |
Models, Immunological | 2 | 0.0 |
Antigen Presentation/*immunology | 2 | 2.0 |
Up-Regulation/drug effects | 3 | 0.0 |
Antigens, CD/metabolism | 2 | 0.0 |
Influenza A Virus, Human/immunology | 2 | 8.0 |
Lymphocyte Activation/drug effects/*immunology | 2 | 4.0 |
Dendritic Cells/classification/*immunology | 2 | 28.0 |
Receptors, CCR5/biosynthesis/genetics | 2 | 22.0 |
Receptors, Cytokine/biosynthesis/genetics | 2 | 33.0 |
Receptors, Chemokine/*biosynthesis/physiology | 2 | 22.0 |
Down-Regulation/drug effects | 3 | 1.0 |
Epitopes, T-Lymphocyte/*physiology | 2 | 66.0 |
Mycobacterium bovis/immunology | 2 | 8.0 |
Inflammation Mediators/metabolism | 2 | 2.0 |
RANTES/biosynthesis | 2 | 11.0 |
Chemokines/biosynthesis | 2 | 5.0 |
Monocytes/physiology | 2 | 1.0 |
